These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17897730)

  • 21. The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging.
    Feld JJ; Colledge D; Sozzi V; Edwards R; Littlejohn M; Locarnini SA
    Antiviral Res; 2007 Nov; 76(2):168-77. PubMed ID: 17709147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx].
    Kim JW; Lee SH; Park YS; Jeong SH; Kim N; Lee DH
    Korean J Hepatol; 2009 Mar; 15(1):15-24. PubMed ID: 19346782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.
    Erhardt A; Göbel T; Ludwig A; Lau GK; Marcellin P; van Bömmel F; Heinzel-Pleines U; Adams O; Häussinger D
    J Med Virol; 2009 Oct; 81(10):1716-20. PubMed ID: 19697400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.
    Chattopadhyay S; Ely A; Bloom K; Weinberg MS; Arbuthnot P
    Biochem Biophys Res Commun; 2009 Nov; 389(3):484-9. PubMed ID: 19733548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GTPase activity is not essential for the interferon-inducible MxA protein to inhibit the replication of hepatitis B virus.
    Yu Z; Wang Z; Chen J; Li H; Lin Z; Zhang F; Zhou Y; Hou J
    Arch Virol; 2008; 153(9):1677-84. PubMed ID: 18668195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered virus-encoded pre-microRNA (pre-miRNA) induces sequence-specific antiviral response in addition to nonspecific immunity in a fish cell line: convergence of RNAi-related pathways and IFN-related pathways in antiviral response.
    Dang LT; Kondo H; Aoki T; Hirono I
    Antiviral Res; 2008 Dec; 80(3):316-23. PubMed ID: 18687362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice.
    Anderson AL; Banks KE; Pontoglio M; Yaniv M; McLachlan A
    J Virol; 2005 Sep; 79(17):11045-52. PubMed ID: 16103155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells.
    Hartwig D; Schütte C; Warnecke J; Dorn I; Hennig H; Kirchner H; Schlenke P
    J Viral Hepat; 2006 Mar; 13(3):150-7. PubMed ID: 16475990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of Namalwa cells on inhibition of HSV-1 replication].
    Wieczorek M; Litwińska B
    Med Dosw Mikrobiol; 2009; 61(2):197-202. PubMed ID: 19780499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adenovirus-mediated delivery of targeted ribonuclease against HBV replication in vitro].
    Gong WD; Lei P; Zhao Y; Liu J; Xue CF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):279-83. PubMed ID: 16546726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-directed gamma interferon gene delivery in chronic hepatitis C.
    Shin EC; Protzer U; Untergasser A; Feinstone SM; Rice CM; Hasselschwert D; Rehermann B
    J Virol; 2005 Nov; 79(21):13412-20. PubMed ID: 16227262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new strategy for constructing in vitro replication-competent 1.3 copies of hepatitis B virus genome.
    Hu JL; Cui J; Deng XY; Zhang WL; Li QL; Guo JJ; Zeng AZ; Huang AL
    J Virol Methods; 2009 Oct; 161(1):63-9. PubMed ID: 19481116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus-mediated shRNA interference against porcine circovirus type 2 replication both in vitro and in vivo.
    Feng Z; Jiang P; Wang X; Li Y; Jiang W
    Antiviral Res; 2008 Mar; 77(3):186-94. PubMed ID: 18199493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adeno-associated virus Rep78 protein inhibits Hepatitis B virus replication through regulation of the HBV core promoter.
    Liu T; Cong M; Wang P; Jia J; Liu Y; Hermonat PL; You H
    Biochem Biophys Res Commun; 2009 Jul; 385(1):106-11. PubMed ID: 19410559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silver nanoparticles inhibit hepatitis B virus replication.
    Lu L; Sun RW; Chen R; Hui CK; Ho CM; Luk JM; Lau GK; Che CM
    Antivir Ther; 2008; 13(2):253-62. PubMed ID: 18505176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.
    Wieland SF; Guidotti LG; Chisari FV
    J Virol; 2000 May; 74(9):4165-73. PubMed ID: 10756029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alpha.
    Xu J; Liu S; Xu Y; Tien P; Gao G
    Virus Res; 2009 Apr; 141(1):55-62. PubMed ID: 19185598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-mediated enhancement of in vitro replication of porcine circovirus type 2 is influenced by an interferon-stimulated response element in the PCV2 genome.
    Ramamoorthy S; Huang FF; Huang YW; Meng XJ
    Virus Res; 2009 Nov; 145(2):236-43. PubMed ID: 19631245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.